Two polymorphisms on the angiotensinogen gene (rs699 and promoter region variants) and one on the angiotensin I converting enzyme gene (an insertion/deletion polymorphism) have been researched as possible links to the physiological pathways behind HC-induced hypertension (11). The gene discussed is AGT; the disease is hypertensive disorder.